Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,432.00
Bid: 1,429.00
Ask: 1,433.00
Change: -3.00 (-0.21%)
Spread: 4.00 (0.28%)
Open: 1,420.00
High: 1,456.00
Low: 1,420.00
Prev. Close: 1,435.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Reckitt To Pay USD1.4 Billion To Settle Probe

Thu, 11th Jul 2019 07:32

(Alliance News) - Stocks in London are set to open higher on Thursday in the wake of dovish remarks by the head of the US central bank and amid a higher oil price. In early company news, Reckitt Benckiser is set to pay up to USD1.4 billion to settle an investigation into practices by former unit Indivior, as Indivior separately announced a boost to its annual guidance following a strong-than-expected first half.IG says futures indicate the FTSE 100 index of large-caps to open 19.61 points higher at 7,550.30 on Thursday. The FTSE 100 index closed down 5.78 points, or 0.1%, at 7,530.69 on Wednesday.Stocks are called for a higher open after US Federal Reserve Chair Jerome Powell left the door open to an interest rate cut this month as he spoke to Congress.In remarks welcomed by Wall Street, Powell said many central bankers believed the case for lower rates "had strengthened" last month given the rising "crosscurrents" in the economy.In his highly anticipated testimony to Congress, Powell repeatedly stressed the importance of keeping the US economy growing to ensure its benefits reach Americans left at the margins and said the central bank will deploy all its tools to support continued expansion."In the wake of Powell's first day of testimony, the market sees a 25-basis-point cut as largely granted. On top, the activity on the US Treasury markets suggests that there are 25% chances for a 50-basis-point cut by the end of this month," noted Ipek Ozkardeskaya, senior market analyst at London Capital Group.In the US on Wednesday, Wall Street ended higher in the wake of Powell's comments, with the Dow Jones Industrial Average ending up 0.3%, the S&P 500 up 0.5% and the Nasdaq Composite up 0.8%.This positive sentiment in stock markets largely flowed through to Asia on Thursday, with the Japanese Nikkei 225 index ending up 0.5%. In China, the Shanghai Composite is down 0.1%, while the Hang Seng index in Hong Kong is 0.8% higher."UK's energy stocks will likely extend their advance as oil prices jumped on hope that the additional monetary stimulus from the Fed could improve the global demand," commented Ozkardeskaya.Brent oil was quoted at USD67.21 a barrel early Thursday, up from USD66.10 late Wednesday.Also boosting the price of oil were ongoing tensions in the Middle East, after the Royal Navy drove off three Iranian vessels which tried to stop a British commercial vessel from travelling through the Strait of Hormuz.The altercation came a day after Iran spoke out against Britain due to the interception of a supertanker believed to be breaching EU sanctions by carrying a shipment of crude oil to Syria."Contrary to international law, three Iranian vessels attempted to impede the passage of a commercial vessel, British Heritage, through the Strait of Hormuz," a Ministry of Defence spokesman told PA.The British Heritage tanker is owned by London-listed BP.On Wednesday Iranian President Hassan Rouhani was quoted by the official IRNA news agency during a Cabinet meeting as saying last week's seizure of the supertanker off Gibraltar was "mean and wrong". He warned London: "You are an initiator of insecurity and you will understand its repercussions," without elaborating.Among listings on the London Stock Exchange, Reckitt Benckiser said it has agreed to pay up to USD1.4 billion to resolve an investigation into the sales and marketing of Suboxone Film. Suboxone Film contains buprenorphine, a controlled substance that is used an an opioid replacement for addicts.The agreement has been reached with the US Department of Justice and the Federal Trade Commission. Suboxone Film is a product owned by Indivior, Reckitt's former prescription pharmaceuticals business which was demerged from the Reckitt group in 2014. Indivior now is separately listed on the London Stock Exchange.The payment will fully resolve all federal investigations into Reckitt in connection to Indivior's indictment and claims relating to state Medicaid programs for those states choosing to participate in the settlement."While RB has acted lawfully at all times and expressly denies all allegations that it engaged in any wrongful conduct, after careful consideration, the board of RB determined that the agreement is in the best interests of the company and its shareholders," said Reckitt. The company continued: "It avoids the costs, uncertainty and distraction associated with continued investigations, litigation and the potential for an indictment at a time of significant transformation under RB 2.0 and during CEO transition."Nurofen painkiller maker Reckitt currently has a provision of USD400 million which it will increase to USD1.5 billion at its half-year results. Separately, Indivior on Thursday raised its guidance following a stronger than expected first half. Indivior - which did not mention the Reckitt announcement in its own on Thursday - now expects net revenue in a range of USD670 million to USD720 million, a sharp increase from previous forecasts of USD525 million to USD575 million. Net income is expected between USD80 million to USD130 million. Prior to this, the company had anticipated anything from a loss of USD40 million to income of USD10 million.The primary driver has been a market share outperformance from Suboxone Film, the company explained. "Our financial performance and strong cash position largely reflect the slower-than-expected pace of erosion of Suboxone Film and the sustained leadership position of the authorized generic buprenorphine/naloxone film that is being marketed by Sandoz," said Chief Executive Shaun Thaxter.Land Securities said Chief Executive Robert Noel intends to retire from the board in 2020. The property investor and developer said it will start a search process to identify his replacement, and Noel will remain in his role until a successor is appointment. Bonding and adhesives firm Scapa Group said its US subsidiary has filed a complaint against FTSE 250-listed medical products firm ConvaTec for breach of contract. This relates to a master supply agreement between ConvaTec and the subsidiary, Scapa Tapes North America. Scapa in June had it had received notice ConvaTec was terminating the agreement. Scapa Tapes is claiming damages of in excess of USD83.8 million. The five-year agreement had been a binding commitment for a minimum of USD30 million of revenue per year. "With the business well positioned for the current market, a growing pipeline and a clear strategy for the future, it's the right time for me to move on," said Noel.Workspace Group said it saw a "good level" of customer demand in a "busy and successful" first quarter for service officecompany. The firm said it saw enquiries averaging 1,060 per month, up from 1,021 a year ago, whiles lettings averages 121 a month versus 88 a year before."It has been a busy and successful quarter for the company. Our distinctive flexible offer continues to attract strong demand from a broad range of customers, despite the challenging economic environment," said Interim Chief Executive Graham Clemett The economic events calendar has US inflation readings at 1330 BST. In addition, the Bank of England will release its financial stability report at 1030 BST and Powell returns to Congress at 1500 BST.

More News
3 May 2024 09:14

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
2 May 2024 13:48

UK shareholder meetings calendar - next 7 days

Friday 3 May 
Ashoka India Equity Investment Trust PLCGM re share issue
HSBC Holdings PLCAGM
Intercontinental Hotels Group PLCAGM
Mondi PLCAGM
More Acquisitions PLCAGM
Monday 6 May 
no events scheduled 
Tuesday 7 May 
Caledonia Mining Corp PLCAGM
CPPGroup PLCAGM
Just Group PLCAGM
Macfarlane Group PLC AGM
Plus500 LtdAGM
Supernova Digital Assets PLCAGM
Wednesday 8 May 
Airea PLCAGM
Antofagasta PLCAGM
Aston Martin Lagonda Global Holdings PLCAGM
Deltex Medical Group PLCAGM
Direct Line Insurance Group PLCAGM
Fidelity European Trust PLCAGM
Haleon PLCAGM
Jardine Matheson PLCAGM
JZ Capital Partners LtdEGM re investing in a secondary fund
Oscillate PLCAGM
Pershing Square Holdings LtdAGM
Rentokil Initial PLCAGM
WPP PLCAGM
Thursday 9 May 
Ascential PLCAGM
BAE Systems PLCAGM
Balfour Beatty PLCAGM
Barclays PLCAGM
CAB Payments Holdings PLCAGM
Catenai PLCGM re convertible loan note
Clarkson PLCAGM
FBD Holdings PLCAGM
Genel Energy plcAGM
Gym Group PLCAGM
Harbour Energy PLCAGM
Hiscox LtdAGM
IMI PLCAGM
Inchcape PLCAGM
Indivior PLCAGM
John Wood Group PLCAGM
Jupiter Fund Management PLCAGM
Logistics Development Group PLCAGM
Man Group PLCAGM
Morgan Advanced Materials PLCAGM
OSB Group PLCAGM
Public Policy Holding Co IncAGM
Rathbones Group PLCAGM
RM PLCAGM
Spire Healthcare Group PLCAGM
Synthomer PLCAGM
Uniphar PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
25 Apr 2024 09:23

Indivior shares down despite profit boost on planned shift to New York

(Alliance News) - Indivior PLC on Thursday saw its shares fall despite reporting a quarterly uptick in profit, as it announced plans to switch its listing to New York.

Read more
25 Apr 2024 08:56

Indivior reports first-quarter growth, confirms plans to shift main listing

(Sharecast News) - Addiction treatment specialist Indivior reported double-digit net revenue growth for the first quarter on Thursday, with total net revenue rising 12% year-on-year to $284m, as it confirmed its intention to shift its primary listing to the United States.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
18 Mar 2024 14:28

IN BRIEF: Indivior CCO Richard Simkin sells GBP1 million in shares

Indivior PLC - Chesterfield, Virginia-headquartered pharmaceutical maker - Chief Commercial Officer Richard Simkin sells 61,285 shares at GBP16.30 each, worth GBP998,946, in London on Thursday. Following this transaction, Simkin is now interested in 117,590 shares.

Read more
12 Mar 2024 09:29

LONDON BROKER RATINGS: UBS cuts abrdn price target but ups Darktrace's

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
8 Mar 2024 20:04

IN BRIEF: Indivior chief commercial officer sells GBP500,000 in shares

Indivior PLC - Chesterfield, Virginia-headquartered pharmaceutical maker - Chief Commercial Officer Richard Simkin sells 30,000 shares on Wednesday at average GBP17.22 each, for a total of GBP516,600.

Read more
7 Mar 2024 12:39

DIRECTOR DEALINGS: Oxford Nanopore Technologies top team buys shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and Thursday and not separately reported by Alliance News:

Read more
29 Feb 2024 19:10

Indivior says US court draws line on multi-district Suboxone case

(Alliance News) - Indivior PLC on Thursday said it received final court approval for a settlement of a multi-district Suboxone litigation case.

Read more
29 Feb 2024 09:47

Indivior receives settlement approval for antitrust litigation

(Sharecast News) - Pharmaceuticals business Indivior has received final court approval for a landmark settlement in an antitrust multi-district litigation with the direct purchaser class.

Read more
22 Feb 2024 16:53

LONDON MARKET CLOSE: European stocks boosted by ECB and Fed minutes

(Alliance News) - Stock prices in Europe closed higher on Thursday, on the back of minutes from the latest European Central Bank and US Federal Reserve meetings.

Read more
22 Feb 2024 16:26

London close: Stocks rise amid raft of solid earnings

(Sharecast News) - London's stock markets finished in positive territory on Thursday, bolstered by upbeat performances from US AI chipmaker Nvidia and engine manufacturer Rolls-Royce.

Read more
22 Feb 2024 11:44

LONDON MARKET MIDDAY: Stocks boosted as UK recession "already" over

(Alliance News) - Stock prices in London were higher at midday Thursday, with the latest UK purchasing managers' index data indicating that the UK recession is "already" over.

Read more
22 Feb 2024 09:55

TOP NEWS: Indivior swings to profit as eyes primary listing move to US

(Alliance News) - Shares in Indivior PLC rose on Thursday, after the company said that strong sales of its flagship Sublocade treatment had pushed its revenue to new heights, and it added that it will begin talks with shareholders to move its primary listing across the Atlantic.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.